世界における緑内障手術デバイスの製品パイプライン動向2015

GlobalDataが発行した調査報告書(GDME0098EPD)
◆英語タイトル:Glaucoma Surgery Devices - Pipeline Review, 2015
◆商品コード:GDME0098EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年10月19日
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,356,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、緑内障手術デバイスのグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。

・緑内障手術デバイスの概要
・緑内障手術デバイスの開発動向:開発段階別分析
・緑内障手術デバイスの開発動向:領域別分析
・緑内障手術デバイスの開発動向:規制Path別分析
・緑内障手術デバイスの開発動向:承認日(推定)別分析
・企業別緑内障手術デバイスの開発動向(パイプライン製品、進行中の治験)
・緑内障手術デバイスの最近動向
【レポートの概要】

Glaucoma Surgery Devices – Pipeline Review, 2015

Summary

GlobalData’s Medical Devices sector report, “Glaucoma Surgery Devices – Pipeline Review, 2015″ provides an overview of Glaucoma Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Glaucoma Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Glaucoma Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Glaucoma Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 8
2 Introduction 9
2.1 Glaucoma Surgery Devices Overview 9
3 Products under Development 10
3.1 Glaucoma Surgery Devices – Pipeline Products by Stage of Development 10
3.2 Glaucoma Surgery Devices – Pipeline Products by Segment 11
3.3 Glaucoma Surgery Devices – Pipeline Products by Territory 12
3.4 Glaucoma Surgery Devices – Pipeline Products by Regulatory Path 13
3.5 Glaucoma Surgery Devices – Pipeline Products by Estimated Approval Date 14
3.6 Glaucoma Surgery Devices – Ongoing Clinical Trials 15
4 Glaucoma Surgery Devices – Pipeline Products under Development by Companies 16
4.1 Glaucoma Surgery Devices Companies – Pipeline Products by Stage of Development 16
4.2 Glaucoma Surgery Devices – Pipeline Products by Stage of Development 18
5 Glaucoma Surgery Devices Companies and Product Overview 20
5.1 Anteis S.A. Company Overview 20
5.1.1 Anteis S.A. Pipeline Products & Ongoing Clinical Trials Overview 20
5.2 AqueSys, Inc. Company Overview 21
5.2.1 AqueSys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 Assenti, LLC Company Overview 25
5.3.1 Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.4 Camras Vision Company Overview 26
5.4.1 Camras Vision Pipeline Products & Ongoing Clinical Trials Overview 26
5.5 Eye Sonix Company Overview 27
5.5.1 Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview 27
5.6 Galaxy Ophthalmics Inc Company Overview 28
5.6.1 Galaxy Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 Geuder AG Company Overview 29
5.7.1 Geuder AG Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 Glaukos Corporation Company Overview 30
5.8.1 Glaukos Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
5.9 InnFocus LLC Company Overview 38
5.9.1 InnFocus LLC Pipeline Products & Ongoing Clinical Trials Overview 38
5.10 Iowa State University Company Overview 41
5.10.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 41
5.11 IPI Singapore Company Overview 42
5.11.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 42
5.12 iScience Interventional, Inc. Company Overview 43
5.12.1 iScience Interventional, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.13 iSTAR Medical Company Overview 44
5.13.1 iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview 44
5.14 Ivantis, Inc. Company Overview 46
5.14.1 Ivantis, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.15 Konan Medical Inc. Company Overview 50
5.15.1 Konan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.16 Kytogenics Pharmaceuticals, Inc. Company Overview 53
5.16.1 Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.17 Massachusetts Eye and Ear Infirmary Company Overview 54
5.17.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 54
5.18 Medtronic plc Company Overview 55
5.18.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 55
5.19 Meir Medical Center Company Overview 57
5.19.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 57
5.20 Ocular Therapeutix, Inc. Company Overview 58
5.20.1 Ocular Therapeutix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.21 Oculox Technology Sagl Company Overview 62
5.21.1 Oculox Technology Sagl Pipeline Products & Ongoing Clinical Trials Overview 62
5.22 Ocumatrx Company Overview 63
5.22.1 Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview 63
5.23 OcuTherix, Inc. Company Overview 64
5.23.1 OcuTherix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.24 OPKO Health, Inc. Company Overview 65
5.24.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.25 OptoLight Vision Technology Company Overview 67
5.25.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 67
5.26 PolyActiva Pty Ltd Company Overview 69
5.26.1 PolyActiva Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
5.27 Queen’s University Company Overview 70
5.27.1 Queen’s University Pipeline Products & Ongoing Clinical Trials Overview 70
5.28 Refocus Group, Inc. Company Overview 71
5.28.1 Refocus Group, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.29 SOLX, Inc. Company Overview 72
5.29.1 SOLX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.30 Tel Aviv University Company Overview 75
5.30.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 75
5.31 TonoGuard Ltd. Company Overview 77
5.31.1 TonoGuard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 77
5.32 Transcend Medical, Inc. Company Overview 78
5.32.1 Transcend Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.33 University of Rostock Company Overview 81
5.33.1 University of Rostock Pipeline Products & Ongoing Clinical Trials Overview 81
5.34 ViSci Ltd. Company Overview 82
5.34.1 ViSci Ltd. Pipeline Products & Ongoing Clinical Trials Overview 82
5.35 Westhouse Medical Services Plc Company Overview 83
5.35.1 Westhouse Medical Services Plc Pipeline Products & Ongoing Clinical Trials Overview 83
6 Glaucoma Surgery Devices- Recent Developments 84
7 Appendix 105
7.1 Methodology 105
7.2 About GlobalData 107
7.3 Contact Us 108
7.4 Disclaimer 108

1.1 List of Tables
Table 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 10
Table 2: Glaucoma Surgery Devices - Pipeline Products by Segment 11
Table 3: Glaucoma Surgery Devices - Pipeline Products by Territory 12
Table 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 13
Table 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 14
Table 6: Glaucoma Surgery Devices - Ongoing Clinical Trials 15
Table 7: Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development 16
Table 8: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 18
Table 9: Anteis S.A. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 10: Drainage Viscoelsatic Injectable Implant - Product Status 20
Table 11: Drainage Viscoelsatic Injectable Implant - Product Description 20
Table 12: AqueSys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 13: XEN45 - Product Status 21
Table 14: XEN45 - Product Description 21
Table 15: AqueSys, Inc. - Ongoing Clinical Trials Overview 22
Table 16: XEN45 - A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys Microfistula Implant in Subjects With Refractory Glaucoma 23
Table 17: XEN45 - A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects with Refractory Glaucoma 23
Table 18: XEN45 - Ab Interno Gelatin Stent with Mitomycin-C Combined with Cataract Surgery for Treatment of Open-angle Glaucoma 23
Table 19: XEN45 - Evaluation of the XEN Implant in Moderate POAG Subjects 24
Table 20: Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
Table 21: Intraocular Pressure Monitoring System - Product Status 25
Table 22: Intraocular Pressure Monitoring System - Product Description 25
Table 23: Camras Vision Pipeline Products & Ongoing Clinical Trials Overview 26
Table 24: Camras Shunt - Product Status 26
Table 25: Camras Shunt - Product Description 26
Table 26: Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview 27
Table 27: Therapeutic Ultrasound Device - Glaucoma - Product Status 27
Table 28: Therapeutic Ultrasound Device - Glaucoma - Product Description 27
Table 29: Galaxy Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 30: Implantable Glaucoma Therapy Device - Product Status 28
Table 31: Implantable Glaucoma Therapy Device - Product Description 28
Table 32: Geuder AG Pipeline Products & Ongoing Clinical Trials Overview 29
Table 33: MikroAug - Product Status 29
Table 34: MikroAug - Product Description 29
Table 35: Glaukos Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
Table 36: GTS400 - Product Status 31
Table 37: GTS400 - Product Description 31
Table 38: iStent Inject - Product Status 32
Table 39: iStent Inject - Product Description 32
Table 40: iStent Supra - Product Status 33
Table 41: iStent Supra - Product Description 33
Table 42: Glaukos Corporation - Ongoing Clinical Trials Overview 34
Table 43: iStent Supra - A Prospective Evaluation of Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin 35
Table 44: iStent Supra - A Prospective, Randomized, Controlled, Parallel Groups Evaluation of Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty 35
Table 45: iStent Inject - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery 36
Table 46: iStent Inject - A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-bypass Stent Model GTS400 in Conjunction With Cataract Surgery 36
Table 47: iStent Inject - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multi-center Clinical Investigation of the Glaukos Trabecular Micro-bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction with Cataract Surgery 37
Table 48: InnFocus LLC Pipeline Products & Ongoing Clinical Trials Overview 38
Table 49: InnFocus Microshunt - Product Status 38
Table 50: InnFocus Microshunt - Product Description 38
Table 51: InnFocus LLC - Ongoing Clinical Trials Overview 39
Table 52: InnFocus Microshunt - InnFocus MicroShunt FDA clinical trial 40
Table 53: InnFocus Microshunt - Post Market Study to Evaluate Safety and Effectiveness of the InnFocus Microshunt (MIDI Arrow) in Patients with Primary Open Angle Glaucoma 40
Table 54: InnFocus Microshunt - Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) to Relieve Glaucoma Symptoms 40
Table 55: Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 41
Table 56: Glaucoma Detection Device - Product Status 41
Table 57: Glaucoma Detection Device - Product Description 41
Table 58: IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 42
Table 59: Pressure-Sensitive Glaucoma Drainage Device - Product Status 42
Table 60: Pressure-Sensitive Glaucoma Drainage Device - Product Description 42
Table 61: iScience Interventional, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
Table 62: Glaucoma Device - Product Status 43
Table 63: Glaucoma Device - Product Description 43
Table 64: iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview 44
Table 65: STARflo MINI - Product Status 44
Table 66: STARflo MINI - Product Description 44
Table 67: STARflo Plus Glaucoma Implant - Product Status 45
Table 68: STARflo Plus Glaucoma Implant - Product Description 45
Table 69: Ivantis, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
Table 70: Hydrus Microstent - Product Status 46
Table 71: Hydrus Microstent - Product Description 46
Table 72: Ivantis, Inc. - Ongoing Clinical Trials Overview 47
Table 73: Hydrus Microstent - A Prospective, Multi-Center, Randomized Controlled Trial to Evaluate the Safety and Effectiveness of the Hydrus Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery 48
Table 74: Hydrus Microstent - A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery 48
Table 75: Hydrus Microstent - A Prospective, Multicenter, Randomized Comparison of the Hydrus to the iStent for Lowering Intraocular Pressure in Primary Open Angle Glaucoma 49
Table 76: Hydrus Microstent - The Safety and Effectiveness of the Hydrus Aqueous Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery, A Prospective, Multicenter, Randomized, Controlled Clinical Trial 49
Table 77: Konan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
Table 78: Bionocular Analytic Dynamic Pupillometer - Product Status 50
Table 79: Bionocular Analytic Dynamic Pupillometer - Product Description 50
Table 80: Konan Medical Inc. - Ongoing Clinical Trials Overview 51
Table 81: Bionocular Analytic Dynamic Pupillometer - The Detection of Glaucoma Using Pupillography 52
Table 82: Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
Table 83: MACC-Based Device - Glaucoma Filtering - Product Status 53
Table 84: MACC-Based Device - Glaucoma Filtering - Product Description 53
Table 85: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 54
Table 86: Pressure Relief Valve Shunt - Product Status 54
Table 87: Pressure Relief Valve Shunt - Product Description 54
Table 88: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 55
Table 89: CellPlant - Product Status 56
Table 90: CellPlant - Product Description 56
Table 91: Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 57
Table 92: Glaucoma Drainage Device - Product Status 57
Table 93: Glaucoma Drainage Device - Product Description 57
Table 94: Ocular Therapeutix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
Table 95: Travoprost Punctum Plug - Product Status 59
Table 96: Travoprost Punctum Plug - Product Description 59
Table 97: Ocular Therapeutix, Inc. - Ongoing Clinical Trials Overview 60
Table 98: Travoprost Punctum Plug - Non-Significant Risk Feasibility Study to Assess Retention and Replacement of the OTX Punctum Plug 61
Table 99: Oculox Technology Sagl Pipeline Products & Ongoing Clinical Trials Overview 62
Table 100: Foldable Intraocular Pressure Sensor Device - Product Status 62
Table 101: Foldable Intraocular Pressure Sensor Device - Product Description 62
Table 102: Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview 63
Table 103: CaPRI Device - Product Status 63
Table 104: CaPRI Device - Product Description 63
Table 105: OcuTherix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
Table 106: Deep Wave Trabeculoplasty Device - Product Status 64
Table 107: Deep Wave Trabeculoplasty Device - Product Description 64
Table 108: OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
Table 109: Aquashunt - Product Status 66
Table 110: Aquashunt - Product Description 66
Table 111: OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 67
Table 112: Lipshitz Macular Implant For Advanced Glaucoma - Product Status 67
Table 113: Lipshitz Macular Implant For Advanced Glaucoma - Product Description 67
Table 114: PolyActiva Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
Table 115: Fully Bioerodible Ocular Implant - Glaucoma - Product Status 69
Table 116: Fully Bioerodible Ocular Implant - Glaucoma - Product Description 69
Table 117: Queen's University Pipeline Products & Ongoing Clinical Trials Overview 70
Table 118: Laser Adjustable Suture - Product Status 70
Table 119: Laser Adjustable Suture - Product Description 70
Table 120: Refocus Group, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
Table 121: PresVIEW Scleral Implant - Glaucoma - Product Status 71
Table 122: PresVIEW Scleral Implant - Glaucoma - Product Description 71
Table 123: SOLX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
Table 124: SOLX Gold Shunt - Product Status 72
Table 125: SOLX Gold Shunt - Product Description 72
Table 126: SOLX, Inc. - Ongoing Clinical Trials Overview 73
Table 127: SOLX Gold Shunt - Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma 74
Table 128: SOLX Gold Shunt - Randomized, Controlled, Multicenter Comparative Trial to Evaluate the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Glaucomatous Eyes Following Failed Medical and Conventional Surgical Treatments 74
Table 129: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 75
Table 130: Direct Laser Trabeculoplasty System - Product Status 75
Table 131: Direct Laser Trabeculoplasty System - Product Description 75
Table 132: Glaucoma Implant - Product Status 76
Table 133: Glaucoma Implant - Product Description 76
Table 134: TonoGuard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 77
Table 135: EasyIOP - Product Status 77
Table 136: EasyIOP - Product Description 77
Table 137: Transcend Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
Table 138: CyPass Micro-Stent - Product Status 78
Table 139: CyPass Micro-Stent - Product Description 78
Table 140: Transcend Medical, Inc. - Ongoing Clinical Trials Overview 79
Table 141: CyPass Micro-Stent - A Multi-center Registry Study to Capture Data with Respect to CyPass Clinical Experience 80
Table 142: CyPass Micro-Stent - A Randomized, Prospective Clinical Evaluation of the Safety and Effectiveness of Visco-assisted CyPass Micro-Stent Implantation in Patients with Open Angle Glaucoma 80
Table 143: University of Rostock Pipeline Products & Ongoing Clinical Trials Overview 81
Table 144: PTX-Eluting Microstent - Product Status 81
Table 145: PTX-Eluting Microstent - Product Description 81
Table 146: ViSci Ltd. Pipeline Products & Ongoing Clinical Trials Overview 82
Table 147: Sub-Conjunctival Drug Implant - Product Status 82
Table 148: Sub-Conjunctival Drug Implant - Product Description 82
Table 149: Westhouse Medical Services Plc Pipeline Products & Ongoing Clinical Trials Overview 83
Table 150: Pneumatic Trabeculoplasty System - Product Status 83
Table 151: Pneumatic Trabeculoplasty System - Product Description 83
Table 152: Glossary 106

1.2 List of Figures
Figure 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 10
Figure 2: Glaucoma Surgery Devices - Pipeline Products by Segment 11
Figure 3: Glaucoma Surgery Devices - Pipeline Products by Territory 12
Figure 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 13
Figure 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 14
Figure 6: Glaucoma Surgery Devices - Ongoing Clinical Trials 15

【掲載企業】

Anteis S.A.
AqueSys, Inc.
Assenti, LLC
Camras Vision
Eye Sonix
Galaxy Ophthalmics Inc
Geuder AG
Glaukos Corporation
InnFocus LLC
Iowa State University
IPI Singapore
iScience Interventional, Inc.
iSTAR Medical
Ivantis, Inc.
Konan Medical Inc.
Kytogenics Pharmaceuticals, Inc.
Massachusetts Eye and Ear Infirmary
Medtronic plc
Meir Medical Center
Ocular Therapeutix, Inc.
Oculox Technology Sagl
Ocumatrx
OcuTherix, Inc.
OPKO Health, Inc.
OptoLight Vision Technology
PolyActiva Pty Ltd
Queen's University
Refocus Group, Inc.
SOLX, Inc.
Tel Aviv University
TonoGuard Ltd.
Transcend Medical, Inc.
University of Rostock
ViSci Ltd.
Westhouse Medical Services Plc

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界における緑内障手術デバイスの製品パイプライン動向2015(Glaucoma Surgery Devices - Pipeline Review, 2015)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆